🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubaa Graft-Versus-Host › Pennsylvania

Qorannoo klinikaalii Dhukkubaa Graft-Versus-Host Pennsylvania keessatti

Qorannoo 6 Dhukkubaa Graft-Versus-Host f Pennsylvania keessatti hirmaatuu jiru.

Magaalota Pennsylvania keessatti

Takkalaa qorannoo (Ingiliffa)

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

  • UMPC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07565220

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  • University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 16-Wax-2026 · NCT04710576

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

  • University of Pittsburgh Medical Center (Data Collection Only), Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 4 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT05675930

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

  • University of Pennsylvania, Philadelphia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT06615050

Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention

  • Penn State Cancer Institute, Hershey
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Elb-2026 · NCT06926595

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Mud-2025 · NCT06619561

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.